lower mortality
[용어속성] Action
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
Research
[키워드] 95% confidence interval
adjusted
age
anticoagulation
association
bleeding
body mass index
Characteristics
confidence interval
COVID-19
COVID-19 patient
Cox proportional hazard
Critical
Critical care
Critically ill
cumulative
daily dose
death
develop
dosage
dose
doses
Dosing
eligible
evaluate
groups
hazard ratio
High dose
High-dose
ICU admission
incidence
initial
intensive care unit
invasive respiratory support
Local
low dose
low molecular weight heparin
low-dose
lower mortality
lower risk
medium
medium dose
Mortality
not differ
Patient
Physiology
Prophylaxis
proportion
recommendations
Registered
Respiratory failure
Result
Retrospective study
risk
risk of death
SARS-CoV-2
score
Sex
three group
thromboembolic complications
Thromboembolic event
Thromboembolism
Thromboprophylaxis
thrombosis
was used
[DOI] 10.1186/s13054-020-03375-7 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13054-020-03375-7 PMC 바로가기 [Article Type] Research
Clinical characteristics of 199 discharged patients with COVID-19 in Fujian Province: A multicenter retrospective study between January 22nd and February 27th, 2020
Research Article
[키워드] 105 patient
Admission
age
analyzed
Characteristics
Chest computed tomography
China
clinical
Clinical characteristics
collected
Comorbidities
Coronavirus disease 2019
correlated
cough
country
COVID-19
COVID-19 severity
Critical
cured
diabete
diabetes
died
discharge
discharged
discharged patient
distress
epidemiological
fatigue
Fever
FIVE
hospital
Hospital stay
hypertension
Hypoxemia
illness onset
laboratory data
lower mortality
Lymphocyte count
lymphopenia
male
median age
Mild
moderate
multicenter
myalgia
nucleic acid test
occurred
old age
one patient
outbreak
oxygenation index
Patient
patients with COVID-19
regression analysis
Respiratory failure
Result
retrospective
Retrospective study
risk factor
severity of COVID-19
Spread
Symptom
Symptoms
syndrome
the median
with COVID-19
Wuhan
Wuhan, China
[DOI] 10.1371/journal.pone.0242307 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0242307 PMC 바로가기 [Article Type] Research Article
Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach
Original Paper
[키워드] 2019-nCoV
Analysis
applicability
applied
approach
association
automated
base
clinical status
Community
computational method
confidence score
coronavirus
coronavirus disease
COVID-19
deep learning
Dexamethasone
disease
Diseases
drug
drug side effects
drugs
effective
effective drug
Effectiveness
effort
entity
Evidence
Genes
help
highlight
human genes
human miRNAs
Hydroxychloroquine
IMPROVE
information
Interaction
Ivermectin
labeling
lower mortality
novel
objective
patients hospitalized
pharmacological treatment
platform
Potential
Preparing
public health
Remdesivir
Research
resources
Result
resulting
SARS
SARS-CoV-2
Scientific community
similarity
statin
statins
Therapeutic treatment
Treatment
Vaccine
with COVID-19
[DOI] 10.2196/21648 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/21648 PMC 바로가기 [Article Type] Original Paper
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
Meta-Analysis
Published on
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 임상, 진단,
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 임상, 진단,
[키워드] 95%CI
adjusted
adjusted RR
adverse event
approach
association
certainty of evidence
citation
Cohort
cohort study
cohorts
concerning
Controlled
COVID-19
COVID-19 patients
COVID-19 severity
Daily
death
did not reduce
Efficacy
elevated
eligibility criteria
eligible
evaluate
evaluated
Evidence
examined
FIVE
Google
higher risk
hospitalized COVID-19 patients
IL-6
IL-6 receptor
Infection
interleukin-6
lower mortality
mechanical ventilation
Meta-analysis
moderate
Mortality
Multiorgan
objective
observational study
observé
Other
OVID
participant
Patient
patients
Placebo
Randomized controlled trial
RCT
RCTs
reduce
Result
risk
risk of bia
Risk of bias
risk ratio
RRs
severe coronavirus disease
Standard of care
syndrome
systematic review
Tocilizumab
Toxicity
treat
Treatment
Web of Science
while
[DOI] 10.1016/j.cmi.2020.10.036 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1016/j.cmi.2020.10.036 PMC 바로가기 [Article Type] Meta-Analysis
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review
Virology
[키워드] 95% CI
absence
Analysis
antiviral therapy
case-control study
cause
characterized
clinical study
clinical trials
Combined
COVID-19
COVID-19 mortality
Critical
cytokine
drug
dysregulated immune response
Effect
effective
Efficacy
Evaluating
Evidence
fatality
group
hypercytokinemia
IL-6
IL-6 inhibitor
include
interleukin-6
lack
lower mortality
lymphocytopenia
Mortality
mortality rate
Odds ratio
pathophysiological
performed
positive
pro-inflammatory cytokine
producing
quantitative synthesis
random effect
Randomized
randomized control trial
reducing
Research
Result
SARS-CoV-2
severe COVID-19
Standard of care
suppress
systematic analysis
systematic review
TCZ
the disease
Tocilizumab
treat
Treatment
Trial
[DOI] 10.7717/peerj.10322 PMC 바로가기 [Article Type] Virology
[DOI] 10.7717/peerj.10322 PMC 바로가기 [Article Type] Virology
How Do COVID-19 Inpatients in the Denver Metropolitan Area Measure Up?
Research Article
[키워드] age
Analysis
analyzed
Area
China
clinical
COVID-19
COVID-19 patient
demographics
discharged
East
expired
hospital
ICU
ICU care
include
Inpatient
intubation
Italy
laboratory-confirmed
lower mortality
measure
mechanical ventilation
Mortality
mortality rates
objective
Older age
outcome
pandemic
participant
Patient
patients
resource
Result
Retrospective study
rising
SARS-CoV-2
setting
Singapore
subset
survival
The United States
transferred
West
with COVID-19
[DOI] 10.1155/2020/8579738 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2020/8579738 PMC 바로가기 [Article Type] Research Article
A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
Research Article
Published on
Journal: The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale [Category] COVID-19,
Journal: The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale [Category] COVID-19,
[키워드] addition
Analysis
Arthritis
benefit
carried
center
Colchicine
colchicine group
comprehensive analysis
condition
Control
control group
control patient
coronavirus disease
COVID-19
CRP
discharge rate
Efficacy
febrile illness
ferritin
Final
form
Future
group
Hyperinflammatory
Impact
Inflammatory marker
inflammatory markers
initial
intubation
lactate dehydrogenase
lower mortality
Medical conditions
moderate
New York City
outcome
patients
patients with COVID-19
performed
placebo-controlled clinical trial
Prevalence
prevalent
Protein
Randomized
receiving
renal
Result
selected
serum
significant decrease
Standard of care
statistically significant
the patient
therapy
were given
[DOI] 10.1155/2020/8865954 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2020/8865954 PMC 바로가기 [Article Type] Research Article
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
Research
[키워드] active cancer
acute respiratory syndrome
adjusted
age
all-cause mortality
analyses
Analysis
Antiviral
antiviral therapy
association
Cancer
Cancer therapy
case sery
Chemotherapy
clinical
Clinical characteristics
Clinical severity
collected
combination therapy
Comorbidities
Comorbidity
Coronavirus-2
COVID-19
COVID-19 in patient
COVID-19 severity
Cox regression
criteria
Cutoff
develop
died
disease severity
evaluate
Health Service
healthcare
Hematologic malignancy
hematologic neoplasms
Hematological malignancy
higher risk
hospital
Immunosuppression
Impact
Infection
IQR
leukemia
Long-term follow-up
lower mortality
lymphoid
male
monoclonal antibody
Mortality
myeloid malignancies
myeloproliferative neoplasm
Non-Hodgkin Lymphoma
outcome
Patient
patients
patients with COVID-19
Prognostic factor
reported
required
respiratory viral infection
Result
risk stratification
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
severity of COVID-19
Sex
shown
solid tumors
Spain
therapy
Treatment
[DOI] 10.1186/s13045-020-00970-7 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13045-020-00970-7 PMC 바로가기 [Article Type] Research
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Research Article
[키워드] acute respiratory syndrome
adaptive immune responses
Adults
age
Anti-spike
Antibody titer
Antibody-dependent cellular phagocytosis
antiviral immune response
caused
CD25
CD4
Cellular immune response
children
circulating
clinical manifestation
clinical outcomes
Concentration
concentrations
coronavirus
coronavirus disease
correlated
COVID-19
cytokine
described
difference
disease
evidenced
Factor
Frequency
generate
hospital
Hospitalization
Hospitalized
human coronaviruses
humoral
identify
IFN-γ
IL-17A
IL-6
immune response
increased expression
Inflammatory
interferon-γ
interleukin-17A
lower mortality
mechanical ventilation
mechanisms
modulate
Mortality
mounted
Necrosis
Neutralizing antibody titer
New York City
no difference
outcome
Patient
patients with COVID-19
pediatric
Pediatric patient
people with COVID-19
Pierce
Protein
response
robust
SARS-CoV-2
SARS-COV-2 infection
serum
Serum neutralizing antibody
syndrome
T cell
T cell response
T cells
TNF-α
viral spike protein
with COVID-19
younger patients
[DOI] 10.1126/scitranslmed.abd5487 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/scitranslmed.abd5487 PMC 바로가기 [Article Type] Research Article